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Peripheral tolerance to developmentally regulated antigens is nec-
essary to sustain tissue homeostasis. We have now devised an
inducible and reversible system that allows interrogation of T-cell
tolerance induction in endogenous naïve and memory CD8 T cells.
Our data show that peripheral CD8 T-cell tolerance can be pre-
served through two distinct mechanisms, antigen addiction lead-
ing to anergy for naïve T cells and ignorance for memory T cells.
Induction of antigen in dendritic cells resulted in substantial ex-
pansion and maintenance of endogenous antigen-specific CD8 T
cells. The self-reactive cells initially exhibited effector activity but
eventually became unresponsive. Upon antigen removal, the anti-
gen-specific population waned, resulting in development of a self-
specific memory subset that recalled to subsequent challenge. In
striking contrast to naïve CD8 T cells, preexisting antigen-specific
memory CD8 T cells failed to expand after antigen induction and
essentially ignored the antigen despite widespread expression by
dendritic cells. The inclusion of inflammatory signals partially over-
came memory CD8 T-cell ignorance of self-antigen. Thus, periph-
eral CD8 T-cell tolerance for naïve CD8 T cells depended on the
continuous presence of antigen, whereas memory CD8 T cells were
prohibited from autoreactivity in the absence of inflammation.
autoimmunity | AIRE | transgenic mouse
Immune tolerance is mediated by multiple mechanisms. Centraltolerance that results in deletion of high-avidity autoreactive T-
cells occurs in the thymus during T-cell development (1, 2). The
deletion process is rendered more robust by the action of the
Aire system, which promotes expression of nonthymic, tissue-
specific proteins in thymic medullary epithelial cells (3). How-
ever, this process is not infallible and self-reactive clones escape
to the periphery where other control mechanisms come into play.
Peripheral tolerance can be mediated through regulatory T cells
(Treg) (4), deletion (5), or the induction of an unresponsive state
known as anergy (5, 6). Aire also operates in the periphery but to
what extent it contributes to each of these tolerance mechanisms
is not yet known (7, 8). In addition, T cells specific for self-
antigens that are developmentally regulated and whose expres-
sion is not controlled by Aire may also be present in the pe-
riphery (1). Many studies using a variety of systems have focused
on the induction of tolerance of adoptively transferred naïve
monoclonal CD4 and CD8 T cells. Few reports have analyzed
tolerance induction of endogenous T cells, and fewer still have
analyzed the potential for the development of tolerance in en-
dogenous memory T cells (9, 10). Memory T cells may be more
relevant to the development of some autoimmune diseases be-
cause preexisting cross-reactive memory cells may react with
tissue-specific antigens through molecular mimicry (11, 12).
However, little is known regarding the mechanisms by which
memory T cells may be tolerized. For example, after the transfer
of memory CD8 T cells to antigen-bearing hosts, the mice be-
come unresponsive, but whether this unresponsiveness is due to
anergy or deletion could not be determined (9), whereas in-
jection of soluble antigen deletes endogenous memory cells (13).
Transgenic systems in which model antigens are expressed under
systemic (14, 15) or tissue-specific promoters (16, 17) have been
used to study T-cell tolerance. Transgenic mice have also been
developed whereby antigen is expressed exclusively by dendritic
cells (DCs) (18) that, in some cases, can be temporally controlled
(19). These models rely heavily on the analysis of adoptively
transferred naïve or memory monoclonal TCR transgenic T cells
because the endogenous antigen-specific T-cell repertoire is dra-
matically altered through deletion via central tolerance. In a more
elegant system, administration of tamoxifen results in antigen ex-
pression in DCs, but this expression is irreversible (10). Expression
of antigen in resting DCs using this model results in tolerance
induction without apparent expansion of antigen-specific CD8
T cells. Again, whether anergy or deletion of the endogenous CD8
T cells is the mechanism of tolerance is not known. Even in a case
where antigen induction is reversible, adoptive transfer of TCR
transgenic T cells was used, likely due to leaky expression of the
transgene, perhaps through the action of Aire (20). We now report
an inducible and reversible system in which endogenous CD8
T cells are ignorant of transgenic antigen. The system allowed us to
observe endogenous CD8 T cells responding to self-antigen and,
importantly, allowed the generation of endogenous memory CD8
T cells before the induction of autoantigen. The results reveal
surprising characteristics of the endogenous naïve and memory
CD8 T-cell responses to developmentally regulated antigen.
Results
Development of an Inducible Antigen System with High Fidelity. We
sought to devise a transgenic system that would allow inducible
antigen expression while maintaining immune system ignorance.
Three transgenic elements were used to control antigen expres-
sion (Fig. S1). The model antigen was a fusion protein (SED)
that encoded an ovalbumin-derived peptide 257–264 [SIINFEKL
(OVA257)], an I-E alpha peptide (aa 52–68) and DsRedII. The
gene encoding this protein was linked to the minimum CMV
promoter under control of the tetracycline operator (tetOSED)
(21). The reverse tetracycline transactivator (rtTA) (22) was ex-
pressed under control of the CD11c promoter (23), restricting
antigen expression to DCs. Tight control of antigen expression was
achieved through inclusion of a tetracycline-controlled transcrip-
tional suppressor (tTS) that was expressed under control of the
β-actin promoter (24).
To test fidelity of the system, CFSE-labeledTCR transgenicOT-I
T cells specific for SIINFEKL (25) were used to assay antigen
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expression. Double transgenic mice expressing only CD11c-rtTA
and tetO-SED (CS) were “leaky” as indicated by loss of CFSE by
a subset of OT-I cells 6 d after transfer (Fig. 1A, Left) and by the
absence of an antigen-specific response after infection (26). OT-I
cells transferred into mice with all three transgenes (CST) did not
proliferate except upon administration of doxycycline (Fig. 1A),
where they expanded >250 fold. To generate a large number of
experimental animals, we produced chimeras (BMC) by injecting
CST bone marrow into lethally irradiated wild-type hosts. These
chimeras also allowed us to study the effects of peripheral toler-
ance in the absence of potential effects from Aire (8, 27), because
antigen expression would be restricted to hematopoietic cells. The
OT-I response in CST BMC mice mimicked the response seen in
intact CST mice, and the amount of OT-I proliferation directly
correlated to the percent of chimerism (Fig. 1A, Right). To de-
termine whether endogenous CD8 T cells were ignorant of the
transgenic antigen in the absence of doxycycline, CST BMC mice
were infected with recombinant vesicular stomatitis virus con-
taining the SED construct (VSV-SED). Similar OVA257 K
b-spe-
cific CD8 T-cell responses were generated in CST BMC and wild-
type C57BL/6 mice (Fig. 1B). We also examined expression of
CD11a (increased upon activation), CD127 (IL-7R, down-regu-
lated by activation), and KLRG1 (induced by inflammation and
a marker for senescent CD8 T cells), and their expression levels
were also similar between WT and CST chimeras. In WT mice or
CST chimeras, control responses to the VSV nucleoprotein (N)
were similar, as was the induction of granzyme B. In addition, the
OVA-specific CD8T cells exhibited similar avidities forOVA257-K
b
by using a tetramer decay assay. Thus, OVA-specific CD8 T cells
were ignorant of the transgene-encoded antigen in the absence
of doxycycline.
Endogenous Naïve CD8 T Cells Undergo Robust Expansion but Not
Deletion to Induced Antigen. We used tetramer enrichment tech-
niques (28, 29) to follow the endogenous antigen-specific T-cell
response upon antigen induction. Antigen induction in CST BMC
mice resulted in a gradual but robust expansion of endogenous
SIINFEKL-specific CD8 T cells whose numbers peaked at ∼day 10
and were maintained in the presence of doxycycline (Fig. 2A). By
day 3 after doxycycline administration, a small population of
activated CD44high antigen-specific CD8 T cells was detected in the
lymphoid tissues, whereas some naive phenotype cells remained
(Fig. 2B). By days 5 and 7, substantial expansion occurred and
nearly all of the responding cells expressed an activated phenotype
(Fig. 2B). Interestingly, during this time, most cells retained high
levels of CD127 (IL-7R), which is generally down-regulated upon
CD8 T-cell activation (30) and did not up-regulate KLRG1, whose
induction is linked to terminal differentiation (31, 32).
By day 10, tetramer+ cells had greatly expanded and were
directly detectable in the blood or tissues without using enrich-
ment (Fig. 3 A and B). The ratio of chimerism (CST:WT) also
correlated with the amount of expansion (Fig. S2). Only by day
Fig. 1. Antigen expression is tightly controlled in triple transgenic mice. (A)
CFSE-labeled Rag−/− OT-I cells (5 × 105) were transferred to the indicated
mice 1 d before administration of 10 μg/mL doxycycline in the drinking
water. Six days later, donor OT-I splenocytes were examined for CFSE loss by
flow cytometry. Values indicate the percentage of OT-I cells among CD8+ T
cells in the spleen. (B) C57BL/6 or CST BMC mice were infected i.v. with 1 ×
105 pfu VSV-SED. Splenocytes were stained with the indicated MHC I tet-
ramers or antibodies and analyzed by flow cytometry 7 d after infection. This
experiment was performed three times with 3–4 mice per group.
Fig. 2. Expansion and activation of endogenous T cells in response to in-
duced self-antigen. CST BMC mice were treated with doxycycline, and the
antigen-specific CD8 T-cell response was monitored. (A) Number of OVA257-K
b
specific T cells over the course of antigen induction. (B) Spleen, peripheral
lymph nodes, and mesenteric lymph nodes were pooled and stained with
OVA257K
b tetramer and anti-CD8 antibody and enriched by magnetic sorting.
Enriched cells were further stained with the indicated antibodies and ana-
lyzed by flow cytometry.
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10 had a subset of responding cells in the blood down-regulated
CD127, and this proportion remained at ∼50% throughout,
whereas few cells up-regulated KLRG1 (Fig. 3A). Similar results
were obtained when cells from lymphoid and nonlymphoid tis-
sues were analyzed 35 d after antigen induction (Fig. 3 A and B).
From day 10 on, most cells expressed high levels of the negative
regulator PD-1 and had down-regulated CD62L (Fig. 3 A and B).
Nonetheless, 10 d after antigen induction the cells expressed
granzyme B and killed target cells in vivo (Fig. S3 B and C). By
day 35 after induction, little cytokine production (IFNγ, IL-2,
TNF) was evident from peptide-stimulated cells (Fig. S3A).
Thus, antigen induction on resting DCs resulted in robust CD8
T-cell expansion and acquisition of effector function. Neverthe-
less, the eventual outcome of continuous antigen encounter was
the development of anergy and maintenance of cell numbers.
Maintenance of Self-Specific CD8 T Cells Requires Antigen. We next
tested whether the long-lived self-specific CD8 T cells were pro-
liferating in response to antigen. To this end, CST BMC were
administered doxycycline for 45 d with BrdU given during the last
week and then splenic tetramer+ cells were analyzed. BrdU was
incorporated by ∼30–40% of the antigen-specific CD8 T cells (Fig.
4A). Nearly all naive OT-I cells transferred to the same mice in-
corporated BrdU (Fig. 4A). Thus, the maintenance of cell numbers
appeared to be due to attrition along with continued proliferation.
We also queried whether antigen was required for the main-
tenance of the responding CD8 T cells. Mice were doxycycline-
treated for 10 d followed by doxycycline removal for 30 d. At 5 d
after doxycycline withdrawal, the frequency of OVA-specific cells
in the blood increased ∼twofold (Fig. 4B), which may be due to
release of T cells from the lymphoid tissues as a result of dis-
ruption of T-cell–DC interactions. From this timepoint on, the
frequency of OVA-specific CD8 T cells slowly waned and the
cells regained CD127 expression but rapidly lost GrzB expres-
sion with gradual loss of PD-1 expression (Fig. 4 B–E). By 33 d
after antigen removal, 50–60% of the tetramer+ cells were mem-
ory phenotype (CD127+KLRG1−) with a smaller population
(∼30%) lacking both CD127 and KLRG1 (Fig. 4C). Tetramer
enrichment at 35 d after doxycycline cessation revealed that
∼1,000 memory phenotype T cells remained in the sampled sec-
ondary lymphoid organs (Fig. 4F). These cells were CD127+
KLRG1− and heterogeneous for CD62L expression (Fig. 4E),
suggesting that both central and effector memory cells had been
produced. We therefore tested whether such memory cells could
respond to VSV-SED infection. In mice previously doxycycline
treated, the OVA-specific response peaked earlier, was of a
higher magnitude, and generated more secondary memory cells
than the response in naïve mice (Fig. 4G). Interestingly, OVA-
specific self-antigen–induced memory cells displayed a higher
avidity for H-2Kb/OVA257 compared with uninduced mice (T1/2 =
18 min compared with 7 min) (Fig. S4), similar to memory cells
responding to infection (26, 33). Thus, even in response to self-
antigen, “avidity maturation” (26) occurred. These results in-
dicated that antigen addiction maintained anergy, whereas re-
moval of antigen resulted in development of memory cells.
Preexisting Antigen-Specific Memory CD8 T Cells Respond Poorly to
Self-Antigen. The ability to generate normal pathogen-specific
responses before antigen induction in our system afforded us the
ability to examine memory T-cell responses to self-antigen. CST
BMC mice were infected with VSV-SED, and memory CD8 T
cells were allowed to develop. Induction of antigen in naïve mice
resulted in expansion of antigen-specific cells and incorporation
of BrdU by most cells (Fig. 5A). In the case of memory cells, in
the absence of doxycycline, ∼10% of the memory CD8 T cells
incorporated BrdU over 7 d, indicative of normal homeostatic
proliferation (Fig. 5B). Surprisingly, when antigen was induced,
antigen-specific memory CD8 T cells did not increase in number
(Fig. S5) and only ∼30% of the cells incorporated BrdU (Fig.
5B). No phenotypic changes indicative of antigen recognition
(CD69 or PD-1 up-regulation or TCR down-regulation) were
detected. Even when doxycycline was administered for >30 d, no
further increase in memory cell proliferation was noted. The
memory cells readily reactivated in response to OVA-expressing
vaccinia virus infection, which induced robust BrdU in-
corporation (Fig. 5C) and an increase in cell numbers (Fig. S5).
We then tested whether the addition of inflammatory signals
Fig. 3. Analysis of self-specific CD8 T cells in lymphoid and nonlymphoid
tissues. (A) Lymphocytes from secondary lymphoid organs were stained as
in Fig. 2A, but without magnetic sorting. (B) Lymphocytes from CST BMC
mice were isolated from indicated organs after 35 d of doxycycline
treatment, stained as indicated, and analyzed by flow cytometry. These
experiments were performed at least two times with a minimum of three
mice per group.
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could overcome the relative ignorance of memory CD8 T cells
for self-antigen. When doxycycline was administered along with
infection by vaccinia virus lacking OVA, BrdU incorporation
increased ∼twofold (from ∼30–60%) compared with control
mice without doxycycline treatment (Fig. 5D). This increase in
proliferation did not, however, result in an increase in cell
numbers (Fig. S5). In addition, in the absence of doxycycline,
infection with vaccinia virus without OVA resulted in an increase
in memory CD8 T-cell proliferation from ∼10% to ∼30% (com-
pare Fig. 5 B–E), likely due to bystander proliferation (34). Thus,
inflammation promoted antigen recognition by memory cells to
a limited extent, but far from the level to which naïve CD8 T cells
responded to self-antigen.
Discussion
One advantage of the inducible antigen model described here is
the ability to add or subtract antigen at will. Although we and
others have described systems where self-antigen is constitutively
expressed or can be irreversibly induced, in most cases, they
suffer from leaky promoter-mediated antigen expression or Aire-
mediated expression resulting in central tolerance. The inclusion
of the transcriptional silencer element in our system blocked
aberrant antigen expression, thereby allowing de novo antigen
induction and withdrawal of antigen. Thus, this system allowed
examination of the endogenous naïve and memory CD8 T-cell
response to temporally regulated self-antigen, without the need
for adoptive transfer of TCR transgenic T cells.
Our findings identified two distinct mechanisms for endoge-
nous naïve and memory CD8 T cells to maintain self-tolerance.
Naïve CD8 T cells responded robustly to self-antigen via direct
presentation by DCs, resulting in transient effector activity
Fig. 4. Maintenance of self-specific CD8 T cells and the generation of
memory T cells by self antigen. (A) OT-I cells were transferred to CST BMC
mice that had been treated with doxycycline for 45 d. The mice were given
BrdU for the next week, and BrdU incorporation was determined in both
endogenous and donor OT-I populations. These experiments were per-
formed at least two times with a minimum of three mice per group. (B–E)
Antigen was induced for 10 d in CST BMC mice and then doxycycline was
withdrawn, and the response was monitored in the blood at the indicated
times for the indicated parameters. SLEC, CD127- KLRG1+ short-lived effector
cells; EEC, KLRG− CD127− early effector cells; MPEC, CD127+ KLRG1− memory
precursor effector cell; DPEC, KLRG1+ CD127+ double positive effector cells. (F)
Cells from secondary lymphoid organs were enriched for tetramer positive cells
and were analyzed by flow cytometry 35 d after doxycycline withdrawal. (G)
Naïve CST BMCmice or mice treated with doxycycline for 10 d followed by 35 d
without doxycyline were infected with VSV-SED. Graph represents the percent
of tetramer+ CD8+ T cells in blood. These experiments were performed three
times with a minimum of three mice per group.
Fig. 5. Pathogen-specific memory cells ignore self-antigen. (A) Cells from
secondary lymphoid organs of CST BMC mice treated with doxycycline and
BrdU for 7 d were stained and enriched for tetramer binding cells. (B–E),
Tetramer+ cells specific for either OVA or VSV nucleoprotein (N) were ana-
lyzed from CST BMC mice infected with 1 × 105 pfu VSV-SED. Sixty days after
infection, mice were given BrdU and additionally treated as indicated with
nothing or with doxycycline (B), or infected i.p. with 1 × 106 pfu recombinant
vaccinia virus expressing either OVA (C) or VSV N (D). Seven days later,
tetramer+ cells in the spleen were quantitated and analyzed for BrdU in-
corporation. Values represent the means derived from at least three mice ±
SEM. This experiment was performed three times with a minimum of three
mice per group.
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followed by anergy induction in the apparent absence of de-
letion. The expansion observed for naïve cells within 10 d after
antigen induction was likely primarily due to the recruitment of
mature naïve CD8 T cells into the response. Nevertheless, over
the course of self-antigen induction, some newly minted T cells
from the thymus may also have been recruited into the response,
which could explain the increased numbers of antigen-specific
CD8 T cells observed after 35 d of antigen induction. This sce-
nario would presumably represent the normal course of events
for tolerance induction to developmentally regulated and/or
tissue-specific antigens in an intact host. However, it is possible
that at later times after antigen induction, deletion was occurring
simultaneously with new input from recent thymic emigrants. It
might also be expected that deletion of antigen-specific cells in
the thymus would occur in response to DC-expressed antigen,
but further studies will be needed to dissect this issue. In-
terestingly, the responding T cells were initially induced to be-
come functionally active, as evidenced by their ability to mediate
antigen-specific cytolysis (Fig. S3B). However, DC numbers
remained stable in antigen-induced mice and, indeed, antigen
continued to be presented because transferred OT-I cells were
able to respond in the context of an ongoing endogenous re-
sponse (Fig. 2C). The eventual induction of anergy also corre-
lated with the sustained expression of PD-1 (Fig. 3A), an inhibitory
receptor associated with T-cell exhaustion and chronic viral in-
fection (35), but other exhaustion markers were not induced.
Thus, signaling via PD-1 may directly inhibit the effector function
of the induced T cells.
Of particular interest was the finding that the immune response
to short-term self-antigen exposure resulted in the generation of
memory CD8 T cells. In fact, self-antigen encounter selected
high-avidity memory cells that were able to mount a secondary
response to subsequent challenge. These data potentially hold
implications for the induction of autoimmunity because a second
exposure to antigen in the face of an inflammatory event could
result in tissue damage. This finding also contrasts with our pre-
vious observations involving central tolerance, where high-avidity
CD8 T-cell clones undergo deletion (26). Similar to virus-induced
memory, the self-antigen–induced memory cells up-regulated
IL-7R and lost PD-1 expression, but unlike a pathogen-induced
response, formation of KLRG1+ short-lived effector cells was
limited, no doubt due to the absence of inflammation (36, 37).
The addition of inflammatory signals during self-antigen induc-
tion may thus change the shape of the observed response as we
have observed in an adoptive transfer system (38).
Remarkably, although naïve CD8 T cells underwent vigorous
expansion in response to self-antigen, preexisting endogenous
memory CD8 T cells largely ignored the antigen, although in-
flammation partially overcame this ignorance. This result appeared
to fly in the face of the long-held tenet that memory T cells are
more readily triggered compared with naïve T cells. Recent results
in virus infection systems also suggest that memory CD8 T cells
may have a preference for particular APC types (39, 40). Our
model predicts that memory T cells have additional requirements
for activation when presented self-peptides either by sequestra-
tion of memory T cells from DCs or by a need for specific cos-
timulation that is not provided by self-antigen in the absence of
inflammation. The mechanism we describe may provide a means
by which memory T cells that cross-react with self-antigens can
be maintained for their protective benefits without the danger
of autoimmunity.
Materials and Methods
Mice. Transgenic mice were generated separately by microinjection of fer-
tilized embryos with constructs containing CD11c-rtTA (C) and tetO-SED (S)
(26). Triple transgenic CST mice were generated by breeding double trans-
genic CS mice with mice expressing tTS (T) under control of the β-actin pro-
moter (24). All animal protocols were approved by the Animal Care Committee
at University of Connecticut Health Center.
Bone Marrow Chimera Production and Analysis. CST chimeras were produced
by transferring ∼1 × 106 anti-Thy1 and complement treated BM cells from
CST mice into lethally irradiated host mice. Some BMC were generated by
mixing CST bone marrow and wild-type bone marrow cells at indicated ra-
tios. For antigen induction, doxycycline (Sigma) was administered in drinking
water (10 μg/mL) with 5% (wt/vol) sugar (Domino). To validate the fidelity of
antigen induction, 5 × 105 CFSE-labeled (Invitrogen) naïve Rag−/− CD45.1.2
OT-I cells were injected i.v. and analyzed by flow cytometry 6 d later. To test
for proliferation of CD8 T cells, BrdU (Sigma) was administered at 0.8 mg/mL
in drinking water with or without doxycycline. Incorporation of BrdU was
determined by using the BD Pharmingen flow kit. To isolate small numbers
of antigen-specific CD8 T cells, magnetic tetramer enrichment of T cells was
performed as described (29).
Flow Cytometric Analysis. Staining was performed by resuspending cells at
106 to 107 cells per mL in PBS containing 0.2% BSA and 0.01% NaN3. OVA and
N-specific T cells were identified by staining with APC-labeled H-2Kb tetra-
mers containing the SIINFEKL epitope (OVA-tetramer) or VSV-nucleoprotein
peptide (N-tetramer) for 1 h at room temperature in the presence of anti-
CD8 (clone 53.6.7), followed by staining with antibodies specific for the in-
dicated molecules at 4 °C for an additional 30 min (all antibodies were
purchased from Biolegend or eBioscience). Cells were washed and fixed with
3% paraformaldehyde/PBS, fluorescence intensities were measured with a
LSR II (BD Biosciences), and data were analyzed by using FlowJo software
(Tree Star). Avidity of T-cell populations was evaluated by decay of tetramer
binding, as described (26).
Analysis of Memory CD8 T Cells. To generate memory cells, CST BMCmice were
infected i.v. with 1 × 105 pfu VSV-SED (41). Sixty days later, the mice were
given doxycycline and subsequently analyzed as detailed in the text.
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